Danny is a long-time freelance photographer and writer. He has covered a wide variety of topics across a large expanse of the globe but specialises in his home country of Malaysia and its surrounds for CBD-Intel. He has also worked for publications such as Esquire, the South China Morning Post, The Sun (Malaysia) and the sadly defunct investigative platform The Nut Graph.
Danny reports on regulation and the industry across the southeast Asian region.
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Do the Novel Food regulations in Europe affect your business?
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.